EA201071120A1 - METHOD OF OBTAINING HETEROARILBENZE DERIVATIVES OF SULFAMATES AND CRYSTALLINE FORM N - ((2S) -6-CHLOR-2,3-DIGYDRO-L, 4-BENZODIOXIN-2-IL) METHYL SULFAMIDE - Google Patents

METHOD OF OBTAINING HETEROARILBENZE DERIVATIVES OF SULFAMATES AND CRYSTALLINE FORM N - ((2S) -6-CHLOR-2,3-DIGYDRO-L, 4-BENZODIOXIN-2-IL) METHYL SULFAMIDE

Info

Publication number
EA201071120A1
EA201071120A1 EA201071120A EA201071120A EA201071120A1 EA 201071120 A1 EA201071120 A1 EA 201071120A1 EA 201071120 A EA201071120 A EA 201071120A EA 201071120 A EA201071120 A EA 201071120A EA 201071120 A1 EA201071120 A1 EA 201071120A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sulfamates
obtaining
derivatives
heteroarilbenze
digydro
Prior art date
Application number
EA201071120A
Other languages
Russian (ru)
Inventor
Ахмед Ф. Абдель-Магид
Стивен Дж. Мехрман
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA201071120A1 publication Critical patent/EA201071120A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C07D321/08—1,4-Dioxepines; Hydrogenated 1,4-dioxepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение направлено на создание способа получения гетероарилбензопроизводных сульфаматов, соответствующих формуле (IA), и кристаллического соединения формулы (I-S), применяемых при лечении эпилепсии и родственных нарушений. Способ получения соединения формулы (IA).The present invention is directed to a method for producing heteroarylbenzene derivatives of sulfamates corresponding to formula (IA) and a crystalline compound of formula (I-S) used in the treatment of epilepsy and related disorders. A method of obtaining a compound of formula (IA).

EA201071120A 2008-03-26 2008-03-26 METHOD OF OBTAINING HETEROARILBENZE DERIVATIVES OF SULFAMATES AND CRYSTALLINE FORM N - ((2S) -6-CHLOR-2,3-DIGYDRO-L, 4-BENZODIOXIN-2-IL) METHYL SULFAMIDE EA201071120A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058233 WO2009120191A1 (en) 2008-03-26 2008-03-26 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide

Publications (1)

Publication Number Publication Date
EA201071120A1 true EA201071120A1 (en) 2011-06-30

Family

ID=40030223

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201071120A EA201071120A1 (en) 2008-03-26 2008-03-26 METHOD OF OBTAINING HETEROARILBENZE DERIVATIVES OF SULFAMATES AND CRYSTALLINE FORM N - ((2S) -6-CHLOR-2,3-DIGYDRO-L, 4-BENZODIOXIN-2-IL) METHYL SULFAMIDE

Country Status (14)

Country Link
EP (1) EP2280950A1 (en)
JP (1) JP2011515464A (en)
KR (1) KR20100126535A (en)
CN (1) CN101981019A (en)
AU (1) AU2008353491A1 (en)
BR (1) BRPI0822454A2 (en)
CA (1) CA2719624A1 (en)
CR (1) CR11761A (en)
EA (1) EA201071120A1 (en)
EC (1) ECSP10010499A (en)
IL (1) IL208222A0 (en)
MX (1) MX2010010595A (en)
WO (1) WO2009120191A1 (en)
ZA (1) ZA201007611B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AU2006249577A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EP2026790A2 (en) 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
BRPI0915890A2 (en) 2008-06-23 2015-11-03 Janssen Pharmaceutica Nv (2s) - (-) - n- (6-chloro-2,3-dihydro-benzo [1,4] dioxin-2-ylmethyl) sulfamide crystalline form
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
CN107954906B (en) * 2017-11-24 2020-10-16 西北师范大学 Synthetic method of aryl sulfonyl tertiary amine compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200612905A (en) * 2004-06-16 2006-05-01 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
KR20070057848A (en) * 2004-08-24 2007-06-07 얀센 파마슈티카 엔.브이. Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
TW200738669A (en) * 2006-02-22 2007-10-16 Janssen Pharmaceutica Nv Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide

Also Published As

Publication number Publication date
MX2010010595A (en) 2010-10-25
WO2009120191A1 (en) 2009-10-01
CA2719624A1 (en) 2009-10-01
EP2280950A1 (en) 2011-02-09
ZA201007611B (en) 2012-04-25
KR20100126535A (en) 2010-12-01
CN101981019A (en) 2011-02-23
JP2011515464A (en) 2011-05-19
AU2008353491A1 (en) 2009-10-01
CR11761A (en) 2011-07-06
IL208222A0 (en) 2010-12-30
BRPI0822454A2 (en) 2015-06-16
ECSP10010499A (en) 2010-10-30

Similar Documents

Publication Publication Date Title
EA201071120A1 (en) METHOD OF OBTAINING HETEROARILBENZE DERIVATIVES OF SULFAMATES AND CRYSTALLINE FORM N - ((2S) -6-CHLOR-2,3-DIGYDRO-L, 4-BENZODIOXIN-2-IL) METHYL SULFAMIDE
EA201200669A1 (en) PYRIDOPYRIMIDINONE INHIBITORS PI3Kα
EA200800760A1 (en) PYRIDOPYRIMIDINONE INHIBITORS PI3Kα
EA201200741A1 (en) METHOD OF OBTAINING DAGIGATRAN ETEXILATE
EA200870193A1 (en) CYTOTOXIC AGENTS, INCLUDING NEW TOMAMYCIN DERIVATIVES, AND THEIR THERAPEUTIC APPLICATION
EA201071264A1 (en) AMINODIGIDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALCHEIMER'S DISEASE
EA201170922A1 (en) DERIVATIVES OF SULFONAMIDE
MX2012003539A (en) Indole derivatives as crac modulators.
EA201100503A1 (en) GLUCOSIDE DERIVATIVES AND THEIR APPLICATIONS
EA201490269A1 (en) NEW DERIVATIVE 1,2,3,4-TETRAHYDROCHINOLINE SUITABLE FOR TREATMENT OF DIABETES
PH12014501417A1 (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
EA200801833A1 (en) METHODS OF OBTAINING CRYSTALLINE FORMS OF DULOXETHINE HYDROCHLORIDE
EA200901563A1 (en) NEW METHOD OF SYNTHESIS OF IVABRADIN AND ITS SALTS OF CONNECTION WITH PHARMACEUTICALLY ACCESSIBLE
EA200900090A1 (en) BENZYLAMINES, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS ANTI-INFLAMMATORY MEANS
NO20082096L (en) Azaindole-2-karboksamidderivativer
NO20083708L (en) 4-Phenyl-thiazole-5-carboxylic acid and 4-phenyl-thiazole-5-carboxylmides as PLK1 inhibitors
CR20160465A (en) POLYMORPH B OF THE N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] BENZAMIDE (MS-275)
EA200801893A1 (en) DERIVATIVES OF TETRAHYDRONAPTALINE, METHOD FOR THEIR PRODUCTION AND THEIR USE AS INFLAMMATION INHIBITORS
EA201590735A1 (en) 2-PHENYL-5-HETEROCYCLYL-TETRAHYDRO-2H-PIRAN-3-AMINE COMPOUNDS FOR APPLICATION IN THE TREATMENT OF DIABETES AND RELATED DISORDERS
EA201170114A1 (en) Method of producing benzimidazole-2-ilpyrimidine derivatives
EA201190293A1 (en) TRIPOLIDA SPIRITS
ECSP10010498A (en) PROCESSES FOR THE PREPARATION OF BENZOFUSED HETEROARILO DERIVATIVES
NO20074047L (en) New process for the production of substituted indoles
EA201792068A2 (en) METHOD OF OBTAINING ORGANIC COMPOUNDS
EA200701852A1 (en) DERIVATIVES OF AMINO ACIDS